Editorials Withdrawal of sibutramine in Europe BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c824 (Published 09 February 2010) Cite this as: BMJ 2010;340:c824 Article Related content Metrics Responses Peer review Related articles Observations When EMA and FDA decisions conflict: differences in patients or in regulation? Published: 22 August 2013; BMJ 347 doi:10.1136/bmj.f5140 Letter Editorial is judgment in advance of the facts Published: 10 March 2010; BMJ 340 doi:10.1136/bmj.c1346 See more Dengue: Argentinians turn to homemade repellent amid surge in cases BMJ April 17, 2024, 385 q885; DOI: https://doi.org/10.1136/bmj.q885 Devolved powers for Greater Manchester led to some health improvements, study shows BMJ March 28, 2024, 384 q767; DOI: https://doi.org/10.1136/bmj.q767 Long waits in child mental health are a “ticking time bomb” regulator warns BMJ March 22, 2024, 384 q724; DOI: https://doi.org/10.1136/bmj.q724 Doctors report big rise in patients with illness because of socioeconomic factors BMJ March 01, 2024, 384 q538; DOI: https://doi.org/10.1136/bmj.q538 Diphtheria: WHO publishes first ever guidance following outbreaks BMJ February 14, 2024, 384 q407; DOI: https://doi.org/10.1136/bmj.q407 Cited by... When EMA and FDA decisions conflict: differences in patients or in regulation?Fulltext PDF Adipose tissue in obesity and obstructive sleep apnoeaFulltext PDF Abstract Sibutramine on Cardiovascular OutcomeFulltext PDF Abstract Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort studyFulltext PDF Abstract Magic bullets now uncontrolledFulltext PDF Abstract Editorial is judgment in advance of the factsFulltext PDF Abstract